Full metadata record
DC FieldValueLanguage
dc.creatorSeidensticker, M. (Max)-
dc.creatorSeidensticker, R. (Ricarda)-
dc.creatorDamn, R. (Robert)-
dc.creatorMohnike, K. (Konrad)-
dc.creatorPech, M. (Maciej)-
dc.creatorSangro, B. (Bruno)-
dc.creatorHass, P. (Peter)-
dc.creatorWust, P. (Peter)-
dc.creatorKropf, S. (Siegfried)-
dc.creatorGademann, G. (Günther)-
dc.creatorRicke, J. (Jeans)-
dc.date.accessioned2015-05-05T14:29:46Z-
dc.date.available2015-05-05T14:29:46Z-
dc.date.created2014-
dc.date.issued2014-
dc.identifier.citationSeidensticker M, Seidensticker R, Damm R, Mohnike K, Pech M, et al. Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity. PLoS ONE 2014;9(11): e112731.es_ES
dc.identifier.issn1932-6203-
dc.identifier.urihttps://hdl.handle.net/10171/38240-
dc.description.abstractThe post-therapeutic application of PTX, UDCA and low-dose LMWH significantly reduced the extent and incidence fRILI at 6 weeks after radiotherapy. The development of subsequent fRILI at 12 weeks (4 weeks after cessation of PTX, UDCA and LMWH during weeks 1-8) in the treatment group was comparable to the control group thus supporting the observation that the agents mitigated fRILI.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Sciencees_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectLiveres_ES
dc.subjectPentoxifylline and ursodeoxycholic acides_ES
dc.titleProspective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicityes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.editorial.noteAttribution 4.0 International (CC BY 4.0)es_ES
dc.identifier.doihttp://dx.doi.org/ 10.1371/journal.pone.0112731es_ES

Files in This Item:
Thumbnail
File
pone.0112731.pdf
Description
Size
3.05 MB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.